highly significantp< 6.93e-05
In particular, the top nine pathways (most highly significant (p< 6.93e-05) were: microRNAs in cancer (hsa05206), endocrine resistance in cancer (hsa01522), EGFR tyrosine kinase inhibitor resistance (hsa01521), FoxO signalling pathway (hsa04068), hepatitis B (hsa05161), pathways in cancer (hsa05200), proteoglycans in cancer (hsa05205), breast cancer (hsa05224) and human papillomavirus infection (hsa05165).